Sumner Andrew Slavin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 26 | 2013 | 1204 | 2.220 |
Why?
|
| Lymphedema | 16 | 2016 | 534 | 1.880 |
Why?
|
| Breast Implantation | 8 | 2014 | 218 | 1.540 |
Why?
|
| Surgical Flaps | 22 | 2011 | 1629 | 1.030 |
Why?
|
| Tissue Expansion | 6 | 2012 | 162 | 0.900 |
Why?
|
| Breast Implants | 10 | 2012 | 387 | 0.860 |
Why?
|
| Mastectomy | 15 | 2013 | 1793 | 0.690 |
Why?
|
| Breast | 10 | 2012 | 1970 | 0.650 |
Why?
|
| Tissue Expansion Devices | 3 | 2012 | 156 | 0.520 |
Why?
|
| Collagen | 5 | 2013 | 2681 | 0.520 |
Why?
|
| Esthetics | 8 | 2012 | 305 | 0.500 |
Why?
|
| Reoperation | 15 | 2013 | 4200 | 0.500 |
Why?
|
| Nipples | 4 | 2009 | 219 | 0.470 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2014 | 484 | 0.470 |
Why?
|
| Erythema | 1 | 2014 | 257 | 0.450 |
Why?
|
| Lipectomy | 5 | 2012 | 119 | 0.400 |
Why?
|
| Postoperative Complications | 10 | 2018 | 15281 | 0.360 |
Why?
|
| Cancer Care Facilities | 2 | 2009 | 402 | 0.350 |
Why?
|
| Abdominal Wall | 2 | 2007 | 157 | 0.330 |
Why?
|
| Lymphocele | 1 | 2008 | 16 | 0.320 |
Why?
|
| Skin Transplantation | 3 | 2012 | 1074 | 0.320 |
Why?
|
| Subcutaneous Fat | 2 | 2012 | 391 | 0.310 |
Why?
|
| Hospitals, Special | 1 | 2008 | 101 | 0.300 |
Why?
|
| Rhytidoplasty | 1 | 2008 | 60 | 0.290 |
Why?
|
| Referral and Consultation | 5 | 2015 | 3530 | 0.290 |
Why?
|
| Thigh | 1 | 2008 | 247 | 0.290 |
Why?
|
| Cicatrix | 3 | 2010 | 763 | 0.270 |
Why?
|
| Breast Neoplasms | 16 | 2012 | 20827 | 0.270 |
Why?
|
| Blepharoplasty | 1 | 2006 | 50 | 0.270 |
Why?
|
| Phlebotomy | 1 | 2005 | 141 | 0.250 |
Why?
|
| Surgical Mesh | 1 | 2007 | 276 | 0.250 |
Why?
|
| Hernia, Ventral | 1 | 2007 | 176 | 0.240 |
Why?
|
| Hematoma | 2 | 2006 | 758 | 0.240 |
Why?
|
| Abdominal Muscles | 4 | 2007 | 166 | 0.240 |
Why?
|
| Prosthesis Design | 1 | 2010 | 2103 | 0.230 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 315 | 0.220 |
Why?
|
| Program Development | 1 | 2009 | 1314 | 0.220 |
Why?
|
| Biocompatible Materials | 2 | 2011 | 1731 | 0.220 |
Why?
|
| Leg | 2 | 2012 | 1116 | 0.220 |
Why?
|
| Lymphatic System | 3 | 2007 | 252 | 0.210 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 633 | 0.200 |
Why?
|
| Rhinoplasty | 3 | 2012 | 226 | 0.200 |
Why?
|
| Female | 68 | 2016 | 380020 | 0.190 |
Why?
|
| Edema | 3 | 2012 | 789 | 0.180 |
Why?
|
| Endoscopy | 1 | 2010 | 1781 | 0.180 |
Why?
|
| Patient Satisfaction | 7 | 2010 | 3391 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 1161 | 0.170 |
Why?
|
| Algorithms | 3 | 2008 | 13869 | 0.170 |
Why?
|
| Muscle, Skeletal | 4 | 2007 | 4925 | 0.160 |
Why?
|
| Patient Selection | 1 | 2010 | 4210 | 0.150 |
Why?
|
| Microsurgery | 3 | 2010 | 785 | 0.150 |
Why?
|
| Transplantation Conditioning | 3 | 2002 | 1599 | 0.150 |
Why?
|
| Thoracic Wall | 2 | 2011 | 203 | 0.150 |
Why?
|
| Bariatric Surgery | 1 | 2007 | 952 | 0.150 |
Why?
|
| Surgery, Plastic | 4 | 2018 | 624 | 0.140 |
Why?
|
| Obesity | 3 | 2016 | 12744 | 0.140 |
Why?
|
| Middle Aged | 40 | 2015 | 213241 | 0.140 |
Why?
|
| Adult | 44 | 2015 | 213889 | 0.140 |
Why?
|
| Scleroderma, Localized | 1 | 1997 | 79 | 0.140 |
Why?
|
| Humans | 75 | 2018 | 743811 | 0.140 |
Why?
|
| Mastectomy, Segmental | 3 | 2006 | 956 | 0.140 |
Why?
|
| Facial Neoplasms | 2 | 1989 | 121 | 0.130 |
Why?
|
| Lipomatosis | 2 | 1989 | 112 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2015 | 12718 | 0.130 |
Why?
|
| Contraceptives, Oral | 1 | 2018 | 564 | 0.130 |
Why?
|
| Syndrome | 2 | 2014 | 3249 | 0.130 |
Why?
|
| Models, Animal | 1 | 2001 | 2172 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2014 | 2052 | 0.120 |
Why?
|
| Surgical Sponges | 1 | 2014 | 46 | 0.120 |
Why?
|
| Mastectomy, Modified Radical | 2 | 2009 | 62 | 0.120 |
Why?
|
| Silicones | 1 | 1995 | 250 | 0.120 |
Why?
|
| Cost of Illness | 2 | 2014 | 1859 | 0.120 |
Why?
|
| Lymphography | 2 | 2008 | 201 | 0.110 |
Why?
|
| Medical Tourism | 1 | 2014 | 57 | 0.110 |
Why?
|
| Implant Capsular Contracture | 1 | 2012 | 22 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3280 | 0.110 |
Why?
|
| Implants, Experimental | 1 | 2012 | 104 | 0.110 |
Why?
|
| Neoplasms, Second Primary | 1 | 2000 | 1063 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5136 | 0.100 |
Why?
|
| Foreign-Body Reaction | 1 | 2012 | 158 | 0.100 |
Why?
|
| Skin, Artificial | 1 | 2012 | 90 | 0.100 |
Why?
|
| Axilla | 2 | 2011 | 597 | 0.100 |
Why?
|
| Lipodystrophy | 1 | 2012 | 147 | 0.100 |
Why?
|
| Tensile Strength | 2 | 2013 | 335 | 0.100 |
Why?
|
| Costs and Cost Analysis | 3 | 2012 | 1680 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1998 | 1100 | 0.090 |
Why?
|
| Nasal Obstruction | 1 | 2012 | 151 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 2008 | 2034 | 0.090 |
Why?
|
| New England | 2 | 2009 | 1022 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 2014 | 400 | 0.090 |
Why?
|
| Connective Tissue Diseases | 1 | 2012 | 264 | 0.080 |
Why?
|
| Quality of Life | 5 | 2014 | 12788 | 0.080 |
Why?
|
| Materials Testing | 1 | 2012 | 866 | 0.080 |
Why?
|
| Fat Necrosis | 1 | 2008 | 58 | 0.080 |
Why?
|
| Occlusive Dressings | 1 | 2008 | 50 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2014 | 15526 | 0.080 |
Why?
|
| Lower Extremity | 2 | 2015 | 1158 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 864 | 0.080 |
Why?
|
| Graft Survival | 5 | 2009 | 3734 | 0.080 |
Why?
|
| Regeneration | 1 | 1997 | 1486 | 0.080 |
Why?
|
| Groin | 1 | 2008 | 105 | 0.080 |
Why?
|
| Horses | 1 | 2008 | 304 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1340 | 0.080 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 372 | 0.080 |
Why?
|
| Safety | 2 | 2005 | 1184 | 0.080 |
Why?
|
| Neck | 1 | 2012 | 698 | 0.070 |
Why?
|
| Treatment Outcome | 10 | 2012 | 63042 | 0.070 |
Why?
|
| Penile Diseases | 1 | 2007 | 44 | 0.070 |
Why?
|
| Fingers | 2 | 1988 | 513 | 0.070 |
Why?
|
| Medical Records | 2 | 2009 | 1412 | 0.070 |
Why?
|
| Retrobulbar Hemorrhage | 1 | 2006 | 11 | 0.070 |
Why?
|
| Fascia | 1 | 2007 | 135 | 0.070 |
Why?
|
| Varicose Veins | 1 | 1988 | 154 | 0.070 |
Why?
|
| Male | 24 | 2016 | 349776 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2015 | 77410 | 0.070 |
Why?
|
| Peritoneum | 1 | 2007 | 227 | 0.070 |
Why?
|
| Aged | 17 | 2015 | 163178 | 0.070 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2007 | 214 | 0.070 |
Why?
|
| Malpractice | 1 | 2010 | 572 | 0.070 |
Why?
|
| Radiotherapy | 1 | 1992 | 1533 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1670 | 0.060 |
Why?
|
| Breast Diseases | 2 | 2006 | 443 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2000 | 5445 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 454 | 0.060 |
Why?
|
| Cocaine | 1 | 1990 | 1007 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2012 | 39001 | 0.060 |
Why?
|
| Laparotomy | 1 | 2007 | 473 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 1998 | 625 | 0.060 |
Why?
|
| Muscles | 1 | 1989 | 1613 | 0.060 |
Why?
|
| Extremities | 2 | 2007 | 867 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 466 | 0.060 |
Why?
|
| Cysts | 1 | 1989 | 678 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 1998 | 9239 | 0.060 |
Why?
|
| Drainage | 1 | 1989 | 1142 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2001 | 3680 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2007 | 729 | 0.060 |
Why?
|
| Skin | 2 | 1993 | 4372 | 0.050 |
Why?
|
| Transplantation, Autologous | 3 | 2007 | 2123 | 0.050 |
Why?
|
| Bone Marrow Purging | 2 | 2002 | 109 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 2 | 2009 | 1476 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 797 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 1999 | 18027 | 0.050 |
Why?
|
| Adolescent | 10 | 2015 | 85729 | 0.050 |
Why?
|
| Vidarabine | 1 | 2002 | 345 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 1 | 2002 | 286 | 0.050 |
Why?
|
| Face | 1 | 2007 | 993 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 1770 | 0.050 |
Why?
|
| Health Care Surveys | 3 | 2014 | 2453 | 0.050 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 378 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2000 | 72 | 0.050 |
Why?
|
| Weight Loss | 1 | 2012 | 2625 | 0.050 |
Why?
|
| Wound Healing | 3 | 2007 | 2776 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2008 | 1062 | 0.050 |
Why?
|
| Fibrosis | 1 | 2006 | 2030 | 0.040 |
Why?
|
| Family | 1 | 2010 | 3144 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2008 | 1154 | 0.040 |
Why?
|
| Carcinoma in Situ | 2 | 2008 | 805 | 0.040 |
Why?
|
| Defecation | 1 | 1979 | 188 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 1999 | 862 | 0.040 |
Why?
|
| Logistic Models | 2 | 2009 | 13404 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2000 | 613 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3058 | 0.040 |
Why?
|
| Technetium Compounds | 1 | 1997 | 15 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12954 | 0.040 |
Why?
|
| Antimony | 1 | 1997 | 19 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 1997 | 61 | 0.040 |
Why?
|
| Hand | 1 | 1983 | 884 | 0.040 |
Why?
|
| Sepsis | 2 | 1983 | 2593 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2014 | 1683 | 0.040 |
Why?
|
| Colloids | 1 | 1997 | 136 | 0.040 |
Why?
|
| Random Allocation | 1 | 2001 | 2429 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2018 | 256 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6363 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 1213 | 0.030 |
Why?
|
| Thoracic Surgery | 1 | 1983 | 719 | 0.030 |
Why?
|
| Consensus | 1 | 2004 | 2954 | 0.030 |
Why?
|
| Young Adult | 5 | 2015 | 56392 | 0.030 |
Why?
|
| Methods | 2 | 1988 | 1128 | 0.030 |
Why?
|
| Risk Factors | 3 | 2010 | 72252 | 0.030 |
Why?
|
| Lectins | 1 | 1997 | 513 | 0.030 |
Why?
|
| Nose | 2 | 2012 | 509 | 0.030 |
Why?
|
| Back | 1 | 1994 | 66 | 0.030 |
Why?
|
| Mastectomy, Simple | 1 | 1993 | 24 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1161 | 0.030 |
Why?
|
| Neoplasm Seeding | 1 | 1994 | 87 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 4254 | 0.030 |
Why?
|
| Animals | 7 | 2012 | 168660 | 0.030 |
Why?
|
| Transplantation, Homologous | 3 | 2000 | 4777 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1875 | 0.030 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 1993 | 46 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2018 | 599 | 0.030 |
Why?
|
| Feces | 1 | 1979 | 1397 | 0.030 |
Why?
|
| Linear Models | 2 | 2014 | 5952 | 0.030 |
Why?
|
| Bandages | 2 | 2006 | 266 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8655 | 0.030 |
Why?
|
| Prognosis | 3 | 2015 | 29052 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 1997 | 402 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 6895 | 0.030 |
Why?
|
| Graft vs Host Disease | 2 | 2002 | 2958 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1596 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1998 | 760 | 0.020 |
Why?
|
| Staphylococcus | 2 | 1983 | 155 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2015 | 23327 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2013 | 504 | 0.020 |
Why?
|
| Specialization | 1 | 2015 | 775 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 2924 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2006 | 8637 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 3912 | 0.020 |
Why?
|
| Blindness | 1 | 2014 | 612 | 0.020 |
Why?
|
| Cause of Death | 1 | 2000 | 3580 | 0.020 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 97 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2298 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 1994 | 484 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 25032 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1990 | 446 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2899 | 0.020 |
Why?
|
| Survival Rate | 2 | 2000 | 12786 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1832 | 0.020 |
Why?
|
| Recurrence | 1 | 2000 | 8337 | 0.020 |
Why?
|
| Acute Disease | 1 | 1999 | 7150 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1256 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 101 | 0.020 |
Why?
|
| Hernia | 1 | 1988 | 70 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1989 | 292 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1994 | 1275 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1999 | 3476 | 0.020 |
Why?
|
| Sensation | 1 | 2009 | 336 | 0.020 |
Why?
|
| Health Status | 2 | 2012 | 4031 | 0.020 |
Why?
|
| Scrotum | 1 | 2007 | 115 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 1998 | 11036 | 0.020 |
Why?
|
| Carcinoma | 1 | 1998 | 2375 | 0.020 |
Why?
|
| Necrosis | 1 | 1990 | 1642 | 0.020 |
Why?
|
| Biopsy | 1 | 1998 | 6750 | 0.020 |
Why?
|
| Perineum | 1 | 2007 | 211 | 0.020 |
Why?
|
| Paraplegia | 1 | 2006 | 169 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9272 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1993 | 3617 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2006 | 155 | 0.020 |
Why?
|
| Time Factors | 4 | 2007 | 40038 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3503 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2006 | 194 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 1653 | 0.020 |
Why?
|
| Cellulitis | 1 | 2006 | 206 | 0.020 |
Why?
|
| Spinal Dysraphism | 1 | 2006 | 161 | 0.020 |
Why?
|
| Posture | 1 | 1989 | 957 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 987 | 0.020 |
Why?
|
| Rats | 2 | 1999 | 24250 | 0.010 |
Why?
|
| Thorax | 1 | 2007 | 547 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2012 | 53250 | 0.010 |
Why?
|
| Enterobacter | 1 | 1983 | 46 | 0.010 |
Why?
|
| Health Education | 1 | 2010 | 1056 | 0.010 |
Why?
|
| Biological Dressings | 1 | 1982 | 30 | 0.010 |
Why?
|
| Body Image | 1 | 2008 | 610 | 0.010 |
Why?
|
| Mice | 2 | 2001 | 81154 | 0.010 |
Why?
|
| Child | 4 | 2015 | 77637 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1841 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20121 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 889 | 0.010 |
Why?
|
| Thermography | 1 | 1983 | 68 | 0.010 |
Why?
|
| Plethysmography | 1 | 1983 | 180 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2008 | 5986 | 0.010 |
Why?
|
| Streptococcus | 1 | 1983 | 197 | 0.010 |
Why?
|
| Raynaud Disease | 1 | 1983 | 75 | 0.010 |
Why?
|
| United States | 3 | 2018 | 69859 | 0.010 |
Why?
|
| Premedication | 1 | 1983 | 258 | 0.010 |
Why?
|
| Mammography | 1 | 1992 | 2475 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1989 | 948 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1983 | 441 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1982 | 454 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2015 | 40545 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2002 | 608 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7270 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1982 | 546 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2006 | 748 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6356 | 0.010 |
Why?
|
| Aneurysm | 1 | 1983 | 339 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13691 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57744 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 35409 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5691 | 0.010 |
Why?
|
| Electromyography | 1 | 1983 | 1378 | 0.010 |
Why?
|
| Body Composition | 1 | 2007 | 2401 | 0.010 |
Why?
|
| Plant Lectins | 1 | 1997 | 104 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 2 | 2002 | 2764 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 1638 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2241 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2006 | 1421 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1982 | 4251 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 3229 | 0.010 |
Why?
|
| Decision Making | 1 | 2010 | 3887 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1989 | 40964 | 0.010 |
Why?
|
| Ischemia | 1 | 1983 | 1907 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1982 | 2251 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 4033 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1999 | 2617 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 7729 | 0.010 |
Why?
|
| Fees, Medical | 1 | 1993 | 117 | 0.010 |
Why?
|
| Remission Induction | 1 | 1997 | 2384 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 3537 | 0.010 |
Why?
|
| Burns | 1 | 1982 | 1815 | 0.010 |
Why?
|
| Cost Control | 1 | 1993 | 624 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13273 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10251 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2002 | 11524 | 0.010 |
Why?
|
| Thrombosis | 1 | 1983 | 2968 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2184 | 0.010 |
Why?
|
| Palliative Care | 1 | 1983 | 3490 | 0.000 |
Why?
|
| Hindlimb | 1 | 1990 | 503 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4848 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1385 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1983 | 7172 | 0.000 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1982 | 228 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1981 | 518 | 0.000 |
Why?
|
| Dogs | 1 | 1981 | 3911 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1990 | 9139 | 0.000 |
Why?
|
| Radiation Dosage | 1 | 1982 | 1928 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1982 | 2951 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1982 | 5524 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 7908 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1982 | 10179 | 0.000 |
Why?
|